Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 136Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Zerbaxa

02 1Zosyn/Tazocin

PharmaCompass

01

Brand Name : Zosyn/Tazocin

Tazobactam

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Zosyn/Tazocin

arrow
euroPLX 86 Munich
Not Confirmed

Tazobactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 200

2018 Revenue in Millions : 230

Growth (%) : -13

blank

02

Brand Name : Zerbaxa

Tazobactam

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Zerbaxa

arrow
euroPLX 86 Munich
Not Confirmed

Tazobactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 130

2019 Revenue in Millions : 0

Growth (%) : 100

blank

03

Brand Name : Zerbaxa

Tazobactam

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Zerbaxa

arrow
euroPLX 86 Munich
Not Confirmed

Tazobactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : -1

2020 Revenue in Millions : 130

Growth (%) : -101

blank

04

Brand Name : Zerbaxa

Tazobactam

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Zerbaxa

arrow
euroPLX 86 Munich
Not Confirmed

Tazobactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 169

2021 Revenue in Millions : -1

Growth (%) : Not Meaningful

blank

05

Brand Name : Zerbaxa

Tazobactam

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Zerbaxa

arrow
euroPLX 86 Munich
Not Confirmed

Tazobactam

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 218

2022 Revenue in Millions : 169

Growth (%) : 29

blank